Colcher D - Search Results

1

Therapeutic advantage of high-affinity anticarcinoma radioimmunoconjugates.

Schlom J, Eggensperger D, Colcher D, Molinolo A, Houchens D, Miller LS, Hinkle G, Siler K. Schlom J, et al. Among authors: colcher d. Cancer Res. 1992 Mar 1;52(5):1067-72. Cancer Res. 1992. PMID: 1310638

2

Serological mapping of the TAG-72 tumor-associated antigen using 19 distinct monoclonal antibodies.

Kuroki M, Fernsten PD, Wunderlich D, Colcher D, Simpson JF, Poole DJ, Schlom J. Kuroki M, et al. Among authors: colcher d. Cancer Res. 1990 Aug 15;50(16):4872-9. Cancer Res. 1990. PMID: 1696162

3

Monoclonal antibody-based therapy of a human tumor xenograft with a 177lutetium-labeled immunoconjugate.

Schlom J, Siler K, Milenic DE, Eggensperger D, Colcher D, Miller LS, Houchens D, Cheng R, Kaplan D, Goeckeler W. Schlom J, et al. Among authors: colcher d. Cancer Res. 1991 Jun 1;51(11):2889-96. Cancer Res. 1991. PMID: 1851665

4

Advantage of dose fractionation in monoclonal antibody-targeted radioimmunotherapy.

Schlom J, Molinolo A, Simpson JF, Siler K, Roselli M, Hinkle G, Houchens DP, Colcher D. Schlom J, et al. Among authors: colcher d. J Natl Cancer Inst. 1990 May 2;82(9):763-71. doi: 10.1093/jnci/82.9.763. J Natl Cancer Inst. 1990. PMID: 2182892

5

Complementation of anti-CEA and anti-TAG-72 monoclonal antibodies in reactivity to human gastric adenocarcinomas.

Ohuchi N, Simpson JF, Colcher D, Schlom J. Ohuchi N, et al. Among authors: colcher d. Int J Cancer. 1987 Dec 15;40(6):726-33. doi: 10.1002/ijc.2910400603. Int J Cancer. 1987. PMID: 2447021

6

Radioimmunotherapy of athymic mice bearing human colon carcinomas with monoclonal antibody B72.3: histological and autoradiographic study of effects on tumors and normal organs.

Esteban JM, Schlom J, Mornex F, Colcher D. Esteban JM, et al. Among authors: colcher d. Eur J Cancer Clin Oncol. 1987 Jun;23(6):643-55. doi: 10.1016/0277-5379(87)90259-8. Eur J Cancer Clin Oncol. 1987. PMID: 2820742

7

Characterization and biodistribution of recombinant and recombinant/chimeric constructs of monoclonal antibody B72.3.

Colcher D, Milenic D, Roselli M, Raubitschek A, Yarranton G, King D, Adair J, Whittle N, Bodmer M, Schlom J. Colcher D, et al. Cancer Res. 1989 Apr 1;49(7):1738-45. Cancer Res. 1989. PMID: 2924317

8

Generation and characterization of B72.3 second generation monoclonal antibodies reactive with the tumor-associated glycoprotein 72 antigen.

Muraro R, Kuroki M, Wunderlich D, Poole DJ, Colcher D, Thor A, Greiner JW, Simpson JF, Molinolo A, Noguchi P, et al. Muraro R, et al. Among authors: colcher d. Cancer Res. 1988 Aug 15;48(16):4588-96. Cancer Res. 1988. PMID: 3396010

9

Radioimmunolocalization of human carcinoma xenografts with B72.3 second generation monoclonal antibodies.

Colcher D, Minelli MF, Roselli M, Muraro R, Simpson-Milenic D, Schlom J. Colcher D, et al. Cancer Res. 1988 Aug 15;48(16):4597-603. Cancer Res. 1988. PMID: 3396011

10

Autoradiographic evaluation of radiolabeled monoclonal antibody B72.3 distribution in tumor and lymph nodes of adenocarcinoma patients.

Roselli M, Hitchcock CL, Molinolo A, Milenic DE, Colcher D, Martin EW Jr, Hinkle GH, Schlom J. Roselli M, et al. Among authors: colcher d. Anticancer Res. 1995 May-Jun;15(3):975-84. Anticancer Res. 1995. PMID: 7645989

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

202 results

Search Page

Filters